Skip to content

Metformin influences progression in diabetic glioblastoma patients

https://pubmed.ncbi.nlm.nih.gov/26329695/

This study of brain cancer patients, 40 of which happened to be diabetic, and 20 of which were on Metformin, compared the outcomes of each patient group and found those on Metformin exhibited longer progression-free survival.

Share on facebook
Share on email
Share on twitter
Share on linkedin

More on Metformin

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments